 Home > Medical News >

Medical Research Articles

European Commission approves expansion of allergy to blinatumomab monodruga treatment

 Time of Update: 2020-06-10

what kills parkinson patients what all cells all therapy pathogen positive bubble study

recently, the US biotech giant Amgen BiTE immunotherapy blinatumomab on EU regulation spout European Commission (EC) has approved the expansion of Blincyto monotherapy for the treatment of adult pa
China's approved slow hepatitis B drug, Wei lide ® officially listed

 Time of Update: 2020-06-10

phentermine drug interactions aetna prescription drug plan lipitor drug aleria drug 3 1 fade

With the increase of hepatitis B vaccination coverage, the number of hepatitis B infection in China has decreased significantly However, the status quo of diagnosis and treatment remains bleak 1/3 p
First phase III clinical study treating breast cancer in the first phase of the first three-year-new targeted cancer drug DS-8201 was treated

 Time of Update: 2020-06-10

hexagonal phase phospholipid fungal breast cancer antibody cells hexagonal phase confirm plateau phase

recently, Daiichi Sankyo, a Japanese pharmaceutical company, announced that the first patient has received treatment for the critical global Phase III clinical study Y-Breast04, a key global clinica
Almirall launches new anti-inflammatory drug Ilumetri (tildrakizumab) in Germany

 Time of Update: 2020-06-10

key eggs anti inflammatory drug disease interaction 2 3 picture 2 4 application rate

recently, Spain's Pharmaceutical (http:// company (http:// Almirall announced the launch of a new anti-inflammatory drug in Germany, Tildrakizumab, for the treatment of adult patients with mode
Uber obtains license for imported drug with anti-epileptic drug Vimpat

 Time of Update: 2020-06-10

fentanyl drug class anti nmda receptor what antagonist drug what function cells ipratropium drug class

recently, the Belgian Pharmaceutical (http:// giant UCB announced that the company (http:// has obtained an imported drug license (IDL) of the anti-epileptic drug from The national drug (ht
Yangzijiang tamoxifen, Anaquzole first through the consistency evaluation

 Time of Update: 2020-06-10

gaba receptors drugs nephron pharmaceutical health care products chemical products soy breast cancer

recently, Yangzijiang Pharmaceutical Group taxifen tablets (10mg), anaquzoltableta (1mg) two anti-tumor products (http:// the first by the imitation of pharmaceutical (http:// quality and effi
NMPA includes new drug listing applications for zanubrutinib and Tirelli Pearl resistance in priority review

 Time of Update: 2020-06-10

pd 1 immunotherapy nexium drug class levothyroxine drug class linzess drug class advair drug class

announced yesterday (November 15) that the National Drug (http:// Regulatory Authority (NMPA) Drug Review Center (CDE) will use the Bruton's tyrosine kinase (BTK) inhibitor zanububinib for the tr
Dermira gets positive results in clinical trial of new drug lebrikizumab2b phase 2b

 Time of Update: 2020-06-10

anti parietal antibody all types slime 1 3 dichloropropene different types soda 3 en 1

today, Dermira (http:// announced that the company developed a new drug (http:// in the treatment of severe isotrophic dermatitis, which in the http:// of the 2b dose increment severity tria
FDA grants Amplyx's candidate drug APX001 orphan drug designated for treatment of cryptococcal disease

 Time of Update: 2020-06-10

strattera drug cbd drug interactions tramadol opiate drug amlodipine drug circle drug test

cryptococcal disease is an infectious disease of the lungs or central nervous system (brain or spinal cord) caused by the fungal cryptococcal (new cryptococcal or gat occultycocci) that is usually f
Johnson and Johnson have filed a license application for stelara's complementary biologics with the FDA.

 Time of Update: 2020-06-10

oxybutynin drug class fda drug regulations hydrocodone drug class 1 2 copper turmeric ulcerative colitis

recently, janson Pharmaceutical (http:// , owned by pharmaceutical (http:// jnd) , announced (http:// that it had submitted an application for a supplemental biological productlicense (sBLA) t
FDA approves Vaxiion's candidate treatment VAX014 research new drug application

 Time of Update: 2020-06-10

liraglutide mechanism action mitosis cancer cells express target engine oil long lasting lubricant

recently, the of the United States announced (http:// that the U.S FDA (http:// has approved its application for a new drug (http:// IND) of its candidate therapy, VAX014 this is the first
Astellas releases DATA from PHASE III ADMIRAL, a targeted cancer drug, xospatinib

 Time of Update: 2020-06-10

diltiazem 30 mg orlistat 120 mg viagra fda approved free ketorolac 30 mg

recently, Japanese drugmaker Astellas released data from the phase III ADMIRAL study (NCT02421939), a targeted cancer drug About Xospata Xospata is a second-generation FLT3 inhibitor, and 2 differ
EMA accepts applications for listing of UC and CD for adult patients with take-field subcutaneous injection type Entyvio (vedolizumab)

 Time of Update: 2020-06-10

phase 5 band ambien active ingredient statistical control chart 2 6 dimethylaniline blue 1 ingredient

recently, Takeda, the giant of Pharmaceutical (http:// in Japan, announced that the European Pharmaceutical (http:// Authority (EMA) had accepted subcutaneous injection form Entyvio (vedolizum
FDA approves Jetbelin Zemaira ® 4g and 5g small bottles to treat alpha1 antitrypsin deficiency

 Time of Update: 2020-06-10

ranibizumab brand name bread new orleans highly internships new jersey pamidronate brand name

recently, CSL Behring announced that the U.S Food and Drug (http:// Administration ( FDA (http:// ) has approved 4 grams and 5 grams of small bottles of Zemaira ® (alpha1 protease inhibitors) to
GENFIT's candidate drug elafibranor for primary bile ductitis 2 study yielded positive results

 Time of Update: 2020-06-10

1 3 dimeth 6 mp drug used paintball markers alpha fetoprotein liver 6 3 uf

recently, bio Pharmaceutical (http:// company (http:// GENFIT announced positive results from the company's candidate drug (http:// elafibranor for the treatment of primary biliary biliary i
NMPA-style approved bird nucleotide cyclase agonist makes Zeshu ® (Linalopeptide) listed in China

 Time of Update: 2020-06-10

fluticasone drug class abdominal pain running human body ph level soot level high mild allergy symptoms

recently, AstraZeneca (http:// announced that the National Drug (http:// Regulatory Authority (NMPA) has officially approved the listing of the world's first (First in class) bird in-class bir
FibroGen announces interim results of Phase 2 clinical trial sparing DMD patients with the drug pamerevlumab

 Time of Update: 2020-06-09

cd 1 2 atlantis study abroad analytical study mechano growth factor soursop cancer treatment

recently, FibroGen (http:// announced the interim results of the pamerevlumab, a drug (http:// for the treatment of Duchenne muscular dystrophy (DMD), in the of the Phase 2 clinical trial (
Nanjing Zhengda Tianqing 3 generic drug "Tegrelo" officially approved by the State Drug Administration (NMPA) for listing

 Time of Update: 2020-06-09

cocaine drug class colony drug generic drug names coreg drug what nitrate drug

yesterday (July 1), Nanjing Zhengda Tianqing 3 imitation Pharmaceutical (http:// "Tegrelo" was officially approved by the State Drug Administration (NMPA) for listing, becoming the third approved
FDA approves Pfizer Vyndaqel and Vyndamax for treatment of myocardial disease caused by amyloid degeneration

 Time of Update: 2020-06-09

cell death disease fast results fda approved tattoo ink alere drug test parainfluenza 3 treatment

AATR-CM is a rare, life-threatening disease It is caused by the instability of the TTR TTR usually exists in the form of tetrapolymers, which, when unstable tetrapolymers are dissofarted, cause setr
FDA approves Mercay Weight PD-1 inhibitor favipiravir

 Time of Update: 2020-06-09

innate immune system fda approved epoxy flu shot effective immune system development 1 2 ghz

today, the (http:// of the of MSD announced that the U.S the FDA's (http:// accelerate the approval of the company's heavy-duty PD-1 inhibitors According to a recent study, researchers at the

Go to Page

Medical Research Articles

European Commission approves expansion of allergy to blinatumomab monodruga treatment

China's approved slow hepatitis B drug, Wei lide ® officially listed

First phase III clinical study treating breast cancer in the first phase of the first three-year-new targeted cancer drug DS-8201 was treated

Almirall launches new anti-inflammatory drug Ilumetri (tildrakizumab) in Germany

Uber obtains license for imported drug with anti-epileptic drug Vimpat

Yangzijiang tamoxifen, Anaquzole first through the consistency evaluation

NMPA includes new drug listing applications for zanubrutinib and Tirelli Pearl resistance in priority review

Dermira gets positive results in clinical trial of new drug lebrikizumab2b phase 2b

FDA grants Amplyx's candidate drug APX001 orphan drug designated for treatment of cryptococcal disease

Johnson and Johnson have filed a license application for stelara's complementary biologics with the FDA.

FDA approves Vaxiion's candidate treatment VAX014 research new drug application

Astellas releases DATA from PHASE III ADMIRAL, a targeted cancer drug, xospatinib

EMA accepts applications for listing of UC and CD for adult patients with take-field subcutaneous injection type Entyvio (vedolizumab)

FDA approves Jetbelin Zemaira ® 4g and 5g small bottles to treat alpha1 antitrypsin deficiency

GENFIT's candidate drug elafibranor for primary bile ductitis 2 study yielded positive results

NMPA-style approved bird nucleotide cyclase agonist makes Zeshu ® (Linalopeptide) listed in China

FibroGen announces interim results of Phase 2 clinical trial sparing DMD patients with the drug pamerevlumab

Nanjing Zhengda Tianqing 3 generic drug "Tegrelo" officially approved by the State Drug Administration (NMPA) for listing

FDA approves Pfizer Vyndaqel and Vyndamax for treatment of myocardial disease caused by amyloid degeneration

FDA approves Mercay Weight PD-1 inhibitor favipiravir